Sansure Biotech Inc.
Status: Publicly traded
Direct answer
Sansure Biotech Inc. is publicly traded on SHH under the ticker 688289.SS.
Sansure Biotech Inc., founded in Changsha, China, in 2008, is dedicated to the global development and commercialization of advanced diagnostic and research products. The company offers a diverse range of solutions, including upstream nucleic acid extraction kits, real-time PCR systems for both clinical and investigative purposes, and fluorescence detection platforms. Their extensive product portfolio encompasses...
Can you invest in Sansure Biotech Inc.?
Yes. Sansure Biotech Inc. trades publicly on SHH as 688289.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sansure Biotech Inc.
Detailed equity research is provided by MarketSnap.